4th Quarter - Report

FRESENIUS MEDICAL CARE NORTH AMERICA for FRESENIUS MEDICAL CARE NORTH AMERICA

Firm
Client
Income
—
Expenses
$1,760,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 8594 and S. 4750, the Restore Protections for Dialysis Patients Act (RPDPA) Labor cost issues related to the ESRD Bundle base rate in the PPS proposed rule HR 7878- The Kidney Health Connect Act Clinical Labor cuts in Prospective Payment System (PPS) rule Dialysis preparedness planning Physician fee schedule conversion factor

Foreign entity interest: Fresenius Medical Care AG and Co. KGaA is the sole indirect owner of Fresenius Medical Care Holdings, Inc. (dba Fresenius Medical Care North America) and has an interest in the issues lobbied.

LobbyistCovered position, as disclosed
LAURA KEMPER —
CAMERON LYNCH —
TALEEN MEKHDJAVAKIAN —
COURTNEY SIMMONE VEATCH New Legislative Assistant; Legislative Counsel - Rep. Neal Dunn. DHS -Office of the General Counsel, Attorney Advisor.

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 7878 (117th), H.R. 8594 (117th), S. 4750 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.